Search PubMed⌕ Search

Biomedical subjects

Attilio Maseri

Publications and source records attributed to Attilio Maseri.

56 records · Page 4Linked to original sources

Prognostic value of pre-discharge exercise testing and serum C-reactive protein in patients with unstable angina.

BACKGROUND: Both exercise testing and C-reactive protein (CRP) serum levels have been shown to predict clinical events in patients with unstable angina. However, no previous study carefully compared their relative prognostic value in this clinical setting. METHODS: We reviewed data of 96 consecutive patients with unstable angina (77 males, 19 females, mean age 63.1 +/- 9.5 years), who were free from clinical events during hospital stay. A symptom/sign-limited treadmill exercise test had been performed and CRP serum levels had been measured prior to discharge in all patients. RESULTS: During an average follow-up of 2.5 years (range 0.5-5 years), there were 8 major cardiac events (death or myocardial infarction) and 11 patients had recurrent unstable angina. Both exercise-induced myocardial ischemia [relative risk (RR) 3.02, 95% confidence interval (CI) 0.58-15.5, p = 0.29], and CRP levels > or = 10 mg/l (RR 2.4, 95% CI 0.51-11.2, p = 0.25) showed a non significant association with major cardiac events. Low workload ischemia, however, was significantly associated with major cardiac events (RR 8.58, 95% CI 1.66-44.2, p = 0.01) and was also the only predictive variable for the combined endpoint of major events and recurrent angina (RR 2.57, 95% CI 1.02-4.44, p = 0.045). Among patients with low workload ischemia, the occurrence of major events was higher in those with high, compared to those with low, CRP levels, but the difference was not significant (28.6 vs 15.4%, p = 0.64). CONCLUSIONS: In this study, pre-discharge myocardial ischemia at low workload was the single most important predictor of major cardiac events during long-term follow-up among patients with stabilized unstable angina. Increased serum CRP levels did not add further significant prognostic information in this specific group of patients with unstable angina, although this issue needs to be addressed in larger studies.

Aged↗

Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.

BACKGROUND: The main limitation of myocardial single photon emission computed tomography (SPECT) in detecting hibernating myocardium is the poor delivery of radiotracers in hypoperfused areas supplied by severely stenotic coronary arteries. Increasing local availability of radiotracers by intracoronary injection might represent an attractive solution. The hypothesis that the intracoronary administration of sestamibi could improve myocardial SPECT accuracy in detecting hibernating myocardium was addressed in this pilot study. METHODS AND RESULTS: Seven patients with prior myocardial infarction and severe stenosis of the infarct-related artery underwent myocardial SPECT after intracoronary injection of technetium 99m sestamibi immediately before percutaneous transluminal coronary angioplasty (PTCA). Wall motion and perfusion were evaluated, before and 1 month after PTCA, by 2-dimensional echocardiography and rest-redistribution thallium 201 SPECT. A "low-flow area" was identified on the pre-PTCA Tl-201 SPECT image as the area with less than 50% of maximum radiotracer uptake. Changes in wall motion and perfusion in the low-flow area were compared with results of intracoronary sestamibi imaging. On a pixel-by-pixel analysis, intracoronary sestamibi predicted perfusion recovery within the low-flow area with a 91% sensitivity, a 78% specificity, and an 82% overall accuracy. Only in the 5 patients with an extent of sestamibi uptake greater than one third of the low-flow area was an improved regional and global left ventricular wall motion observed after PTCA (wall motion score index decreased from 1.95 +/- 0.28 to 1.60 +/- 0.34, P =.007; left ventricular ejection fraction increased from 42% +/- 7% to 49% +/- 7%, P =.001; asynergic segments in the low-flow area decreased from 3.6 +/- 0.9 to 1.8 +/- 1.5, P =.021). CONCLUSIONS: In patients with prior myocardial infarction and severe stenosis of the infarct-related artery, sestamibi uptake after intracoronary administration identified viable myocardium that was undetected after rest-redistribution thallium SPECT but capable of clinically significant contractile improvement after revascularization.

Adult↗